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Abstract
Background: Schizophrenia (SC) and bipolar disorder (BD) are among the most devastating diseases worldwide. There
are several lines of evidence suggesting that viruses may play significant roles in the etiology of these mental disorders.
The aim of this study was the detection of HHV-6A/B in the peripheral blood mononuclear cells (PBMC) of SC and BD
patients versus the healthy control (HC) subjects using a new method of type-specific Real time PCR analysis.
Methods: A type-specific Real time PCR was performed for simultaneous detection and typing of HHV-6A/B in the
PBMCs of 120 SC and BD patients and 75 HCs.
Results: Only one case of HHV-6B out of 120 (0.8 %) SC and BD patients and two cases of HHV-6A (2.7 %) in 75 HCs
were detected.
Conclusions: The low levels of HHV-6 detection in PBMCs, severely limited the capacity of this study to investigate the
association between the presence of HHV-6 and BD or SC in this population, thus no conclusions can be drawn in this
regard. Meanwhile this study introduces a Real time PCR based method for type specific detection of HHV-6A/B in
clinical samples.
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Background
Schizophrenia (SC) and bipolar disorder (BD) are debili-
tating mental illnesses distributed worldwide. Various fac-
tors have been implicated in the etiology and pathogenesis
of these major mental disorders. There is controversial
evidence to indicate that infectious organisms might have
a role in affecting the etiologic pathways implicated in
psychiatric diseases such as SC and BD [1]. Viral agents,
due to their potential latency and neurotropism are con-
sidered as possible agents in the pathogenesis of many
central nervous system (CNS) disorders [2]. Herpes vi-
ruses have been supposed as the key pathogenic factors in
mental diseases [3]. The human herpes virus 6 (HHV-6)
was first isolated in 1986 by Salahuddin and coworkers
[4, 5]. The HHV-6 virus infects most infants under the
age of 12 months and almost 100 % of the population
in adulthood is seropositive for this virus [6]. Two spe-
cies of the virus (A and B) have been identified [7] with
88–96 % nucleotide sequence homology [8]. Human
herpes virus 6B is the cause of the common childhood
disease, exanthema subitum [9, 10]. The pathologic
characteristics of HHV-6A are less known but it ap-
pears to be more neurotropic. Nowadays the number of
diseases associated with HHV-6 infection is increasing.
HHV-6 may play a pathogenic role in neurologic disor-
ders such as epilepsy, multiple sclerosis as well as skin
diseases [11–13].
As HHV-6 is predominantly a T-cell tropic virus, the
purpose of this study was the detection of HHV-6A/B in
the peripheral blood mononuclear cells (PBMC) of SC
and BD patients versus the healthy control (HC) subjects
using a type specific Real time PCR analysis.
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Methods
Patients
Blood samples were obtained from 120 BD and SC
patients (60 BD and 60 SC) diagnosed according to
DSM-IV diagnostic criteria using the Structured Clinical
Interview for DSM-IV Axis I Disorders (SCID-1) [14].
Patients were hospitalized between March to September
2013 in Iran Mental Hospital located in Tehran. The
medical history and demographic data were recorded on
standard forms. Patients with substance abuse, mental
retardation, epilepsy, history of head trauma or enceph-
alitis and any other neurologic disorder were excluded.
The study was approved by the ethics committee of
Tehran University of Medical Sciences. All participants
signed written informed consent after explaining the
study procedures.
A population of 75 healthy individuals without a history
of mental and neurological illnesses and hospital admis-
sion were selected as control subjects [15]. Geographic
region, sex, age and socioeconomic status were matched
between the case and control groups.
Preparation of PBMCs
For the isolation of PBMCs, 10 ml of blood was drawn
by venipuncture in the presence of anticoagulant. The
peripheral blood mononuclear cells were separated using
lymphocyte separation medium (Ficoll-paque™-plus) and
stored in liquid nitrogen until use.
DNA extraction
High Pure Viral Nucleic acid kit (Roche, Germany) was
used for DNA extraction from PBMCs. Concentration of
the extracted DNA was determined by measuring ab-
sorbance at 260 nm.
Beta-globin PCR
Beta-globin PCR with specific primers (Forward- ACA
CAACTGTGTTCACTAGC & Reverse- CAACTTCATC
CACGTTCACC) was used as indicator of the quality of
the extracted DNA from the blood samples.
Type specific Real time PCR
We performed a Quantitative Real time PCR assay which
can detect HHV-6A/B within one reaction by two probes
that have only one nucleotide difference with different
reporters and quenchers. The FAM/TAMRA probe de-
tects HHV-6A and Joe/BHQ-1 probe detects HHV-6B.
The sequence of the primers and probes are shown in
Table 1.
Positive and negative controls were included in each
assay. The positive control was purchased from the
Vircell Company. The concentration of HHV-6 control
DNA was 106 copies/μL. The assay was validated by
using a 10-fold dilution series of the positive control.
The detection limit for the Real time PCR was 20 copies
of DNA /μL (Fig. 1).
The test was carried out with Qiagen Probe Real
time PCR kit (Germany). The thermocycling procedure
consisted of denaturation at 95 °C for three minutes,
45 cycles of denaturation at 95 °C for 15 s, annealing
at 55 °C for 30 s and extension at 60 °C for 30 s. The
Applied Biosystems StepOne Plus machine was used
for PCR amplification.
Statistical analysis
Categorical variables are reported through frequencies
(percentages) and continuous variables are presented as
mean (SD). The Independent t test was used to compare
the mean of continuous variables between the cases and
controls. The distribution of qualitative variables was
compared through Chi-squared and Fisher’s exact tests
between the groups. Statistical analysis was performed
using SPSS 18.0 software (SPSS Inc., Chicago, IL, USA).
P-values less than 0.05 were considered statistically
significant.
Results
Type specific Real time PCR
A total of 120 patients (60 SC and 60 BD) and 75 HCs
were included in this study. To investigate the preva-
lence of HHV-6A/B, a method of type specific Real time
PCR with two different probes was used to test the pres-
ence of HHV-6A/B in DNA extracted from the PBMCs.
Only one case of HHV-6B out of 120 (0.8 %) SC and BD
patients and two cases of HHV-6A (2.7 %) in 75 HC
subjects were detected in total samples. One hundred
copies of viral DNA were detected in the positive sam-
ples. No association was found between HHV-6 infec-
tion and SC and BD.
Table 1 The sequences of type-specific Real time PCR primers and probes
Primers Sequences
HHV6U41-F4 5′- CGGAACATTGTTGAGCAGAAA-3′
HHV6U41-R106 5′- AAGAAGAATCCCTTGTCTGGC-3′
Probes Sequences
HHV6U41-ProbeA FAM-CTCTAAGCACGAAATCTTCACATTCGGAAACA-TAMRA
HHV6U41-ProbeB JOE-CTCTAAGCACGAAATTTTGACATTCGGAAACA-BHQ1
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Demographic characteristics of the study population
In SC patients there was no difference in season of birth
(25 % was born in each season) but in BD patients 35 %
were born in winter, 25 % in spring, 25 % in summer
and 15 % in autumn. The single BD patient positive for
HHV-6B was born in spring with a family history of BD.
Ethnicity, country of origin and socioeconomic status,
were similar across the groups. Other demographic char-
acteristics are shown in Table 2.
Discussion
The detection of HHV-6 DNA in PBMCs and plasma
has been proposed as a marker of latent and active viral
replications, respectively [16]. As the detection of HHV-
Fig. 1 Standard curve obtained by 10-fold dilution series of the positive control
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6 in plasma might be negative while positive in PBMCs
[17], this study was performed for detection of HHV-6A/
B in PBMCs of SC and BD patients with a type specific
Real time PCR and compared the results with HCs to find
the latent infections. However, the detection level of
HHV-6 in PBMCs was very low, which limited the ability
of this study to investigate differences between the con-
trols and BD or SC patients in this study population.
Schizophrenia and BD are polygenic mental disorders
with major contribution of developmental and environ-
mental factors [18]. Although several lines of evidence
indicates that infectious agents may play a role in the
pathogenesis of SC and BD, there is no strong research
data showing a definite link between viral agents and
these neuropsychiatric disorders.
Herpes viruses have been generally considered as poten-
tial contributing factors in the development of psychiatric
disorders. Human herpes virus 6 is a member of the family
of herpesviridae and the subfamily of betaherpesvirinae
and is associated with widespread infections in humans
[19]. Problems related to HHV-6 infections are ranged
from simple infections to neuropsychiatric complications,
though there are diagnostic challenges and therapeutic ap-
proaches to be addressed [20]. While two distinct species
of HHV-6 have been identified, exanthema subitum as the
first point of recognizing HHV-6 infection mostly occurs
with HHV-6B [21]. The human herpes virus-6A is more
prevalent than HHV-6B in patients with neurological
diseases [22]. In a study by Nitsche et al. [23] on paired
samples of peripheral blood leukocytes (PBL) and plasma
of 25 patients with bone marrow transplant and 30 HCs,
the load of HHV-6A DNA in plasma was higher than
HHV-6B, but in HCs no HHV-6A/B DNA was detected
in PBL and plasma.
The neuroinvasiveness of HHV-6 is contingent to the
fact that its DNA is frequently found in specimens from
different regions of the human brain [24–29]. Until now
the hypothesis on the association between HHV-6 and
psychotic diseases remains interesting, though unproven.
It was stated that the HHV-6 latent protein, SITH-1, may
contribute in the increased risk of mood disorders in
chronic fatigue syndrome and psychosis (Kobayashi N,
Shimada K, Kuratsune H, Kondo K: Identification of novel
HHV-6 neurovirulent latent protein that causes mood dis-
orders in CFS, psychosis and HHV-6 en cephalopathy,
Unpublished data). In contrast Fukuda et al. [30] found no
increase in HHV-6 antibody in paired sera of eight pa-
tients with the acute exacerbation of SC.
This case–control study analyzing 120 patients with
SC and BD and 75 HCs found no evidence for the
Table 2 Demographic characteristics of study population
Cases Controls (N = 75) P-value
SC BD Total
(N = 60) (N = 60) (N = 120)
Age
Mean (SD) 35.95 (9.99) 35.87 (11.58) 35.91 (10.77) 35.59 (10.74) 0.839a
Sex
Male (%) 46 (76.7 %) 32 (53.3 %) 78 (65.0 %) 48 (64.0 %) 0.887b
Female (%) 14 (23.3 %) 28 (46.7 %) 42 (35.0 %) 27 (36.0 %)
Marital status
Single (%) 41 (68.3 %) 31 (52.5 %) 72 (60.5 %) 35 (48.5 %) 0.090c
Married (%) 17 (28.3 %) 27 (45.8 %) 44 (37.0 %) 37 (51.4 %)
Divorced (%) 2 (3.4 %) 1 (1.7 %) 3 (2.5 %) 0 (0.0 %)
Family history
Yes (%) 18 (30.0 %) 26 (43.3 %) 44 (36.7 %) - -
No (%) 42 (70.0 %) 34 (56.7 %) 76 (63.3 %)
Hospital Admission history
Yes (%) 58 (96.7 %) 56 (93.4 %) 114 (95 %) - -
No (%) 2 (3.3 %) 4 (6.6 %) 6 (5 %)
Smoking
Yes (%) 31 (61.7 %) 14 (23.3 %) 45 (37.5 %) 8 (10.7 %) <0.001b
No (%) 29 (48.3 %) 46 (76.7 %) 75 (62.5 %) 67 (89.3 %)
SC Schizophrenia, BD Bipolar disorder, SD Standard deviation
aSignificances of all cases vs. controls are based on t-test
bSignificances of all cases vs. controls are based on Chi- square test
cSignificances of all cases vs. controls are based on Fisher-exact test
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association of HHV-6 with SC and BD using type-
specific Real time PCR analysis. This method provides a
rapid and type-specific assay for detecting and genotyp-
ing HHV-6 in clinical specimens. According to this
assay, HHV-6B was detected in a 27 years old female
with BD and HHV-6A was found in two HCs without a
history of any psychiatric disorders. Overall this study
was not able to detect any statistical significant differ-
ences in the prevalence of HHV-6 DNA in patients
with SC and BD in comparison with HCs. Therefore, it
remains controversial whether HHV-6 infection is asso-
ciated with SC and BD in humans. Hence, further stud-
ies on different samples, specially CSF and brain
biopsies using other advanced diagnostic tools are rec-
ommended to elucidate the presence of HHV-6 in these
patients.
Many studies have shown that individuals with SC
have 5–15 % excess of winter and spring births [31–33]
which is not observed in SC patients of the present
study. Similar to our findings, some studies on patients
with BD have shown a winter-spring seasonal birth excess
[1] which might be the result of higher viral exposures
during these seasons.
Our current study has a number of limitations to be
under consideration in future studies. First, we have not
been able to differentiate and exclude the carriers of ci-
HHV-6. Second, PCR analysis of specimens from brain
biopsy and CSF for HHV6A/B should be more specific
and sensitive for diagnosing HHV-6 related to psychotic
disorders. While brain biopsy has many ethical limitations
in living individuals, with the current state of knowledge
we have no convicting evidence to collect CSF samples
from these individuals. Third, there are not adequate
numbers of studies about HHV-6 in psychotic patients to
verify the results of our findings. Forth, with a moderate
sample size we initially designed this study to use a sensi-
tive method for detection of HHV-6 DNA in PBMCs to
uncover latent infections in patients and HCs. Next, we
planned to continue this study for the detection of viral
DNA in plasma and compare the viral load in patients
and HCs to find active infection and its possible relation-
ship with these diseases. However because of the low de-
tection rate in PBMCs we decided to stop working on
plasma with the current sample size.
Conclusion
In conclusion, there was a lack of association of HHV-6
infection with SC and BD in the present study and huge
challenges are remained to elucidate the etiology of SC
and BD in humans.
Meanwhile, as there is not a single type-specific assay
to detect HHV-6A/B, we recommend this Real time
PCR based assay for rapid and simultaneous detection
and typing of the HHV-6A/B viruses.
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